福岡大学病院は、福岡県福岡市城南区にある大学病院である。

During the past decade, Fukuoka University Hospital conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 34 clinical trials were completed, i.e. on average, 34.3% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 32 clinical trials were completed. i.e. 59.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fukuoka University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 14 trials, followed by "Boehringer Ingelheim" with 12 trials sponsored, "Bayer" with 9 trials sponsored, "Pfizer" with 9 trials sponsored and "Eli Lilly and Company" with 9 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fukuoka University Hospital" #1 collaborator was "Eli Lilly and Company" with 6 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Boehringer Ingelheim" with 2 trials as a collaborator and "Japan Lung Cancer Society" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Fukuoka University Hospital" are "Ulcerative Colitis" (13 trials), "Crohn's Disease" (10 trials), "Psoriasis" (7 trials), "Heart Failure" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "Fukuoka University Hospital" in a lesser frequency.

Most popular intervention types in "Fukuoka University Hospital" are "Drug" (98 trials), "Other" (10 trials), "Biological" (4 trials), "Behavioral" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "Apremilast" (5 trials), "Etrasimod" (5 trials), "Mirikizumab" (5 trials) and "Empagliflozin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Fukuoka University Hospital" are 107 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Fukuoka University Hospital". undefined are not yet recruiting, 26 are recruiting, 19 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in Fukuoka University Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Fukuoka University Hospital, 2 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".